Viemed Healthcare (VMD) Invested Capital (2018 - 2026)

Viemed Healthcare (VMD) has reported Invested Capital for 9 consecutive years, with $153.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 4.9% year-over-year to $153.1 million; the trailing twelve-month figure through Jun 2026 stood at $153.1 million (up 4.9% YoY), and the FY2025 full-year result was $155.9 million, up 13.55% from the prior year.
• Invested Capital eased to $153.1 million in Q2 2026 per VMD's latest filing, from $155.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $156.6 million in Q3 2025 and bottomed at $97.1 million in Q4 2022.
• Historically, Invested Capital has averaged $128.4 million across 5 years, with a median of $130.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Invested Capital fell 3.49% in 2022, then grew 24.59% in 2023.
• Over 5 years, Invested Capital stood at $97.1 million in 2022, then climbed by 24.59% to $121.0 million in 2023, then gained by 13.5% to $137.3 million in 2024, then increased by 13.55% to $155.9 million in 2025, then decreased by 1.83% to $153.1 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $153.1 million, $155.0 million, and $155.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.